Get the Stockscreener App
2.20
1.38%
0.03
After Hours:
2.38
0.18
+8.18%
Mangoceuticals Inc stock is traded at $2.20, with a volume of 339.42K.
It is up +1.38% in the last 24 hours and up +0.46% over the past month.
Mangoceuticals Inc focuses on developing, marketing, and selling a variety of men's wellness products and services through a telemedicine platform. The company's platform provides access for customers to a licensed pharmacy for online fulfillment and distribution of certain medications that may be prescribed as part of telehealth consultations, including Mango ED products.
See More
Previous Close:
$2.17
Open:
$2.31
24h Volume:
339.42K
Relative Volume:
2.01
Market Cap:
$24.82M
Revenue:
$755.00K
Net Income/Loss:
$-9.33M
P/E Ratio:
-0.3853
EPS:
-5.71
Net Cash Flow:
$-5.43M
1W Performance:
-3.08%
1M Performance:
+0.46%
6M Performance:
+40.13%
1Y Performance:
-32.00%
1-Day Range:
$2.08
$2.355
1-Week Range:
$2.08
$2.61
52-Week Range:
$1.32
$6.15
Mangoceuticals Inc Stock (MGRX) Company Profile
Name
Mangoceuticals Inc
Sector
Industry
Phone
(833) 626-4679
Address
15110 DALLAS PKWY, SUITE 600, DALLAS
Compare MGRX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MGRX
Mangoceuticals Inc
|
2.20 | 24.82M | 755.00K | -9.33M | -5.43M | -5.71 |
|
VEEV
Veeva Systems Inc
|
286.59 | 48.92B | 2.97B | 809.93M | 1.33B | 4.8743 |
|
TEM
Tempus Ai Inc
|
96.39 | 17.25B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
65.61 | 13.59B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
90.52 | 7.99B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
35.70 | 7.14B | 906.14M | -52.62M | 89.62M | -0.3621 |
Mangoceuticals Inc Stock (MGRX) Latest News
Will Mangoceuticals Inc. continue its uptrendJuly 2025 Short Interest & AI Based Buy and Sell Signals - newser.com
Quantitative breakdown of Mangoceuticals Inc. recent moveShare Buyback & Stock Portfolio Risk Management - newser.com
Understanding Mangoceuticals Inc.’s price movementTrade Analysis Summary & AI Enhanced Market Trend Forecasts - newser.com
Is Mangoceuticals Inc. building a consolidation baseGold Moves & Free Safe Capital Growth Stock Tips - newser.com
Using flow based indicators on Mangoceuticals Inc.Portfolio Return Summary & Risk Controlled Stock Pick Alerts - newser.com
What candlestick patterns are forming on Mangoceuticals Inc.2025 Risk Factors & Real-Time Stock Entry Alerts - newser.com
Why Mangoceuticals Inc. stock is a value investor pickDip Buying & Stock Portfolio Risk Management - newser.com
Mangoceuticals announces 1-for-15 reverse stock split - MSN
Mangoceuticals alters stockholder rights, amends bylaws - MSN
Published on: 2025-09-29 03:12:46 - newser.com
What analysts say about Mangoceuticals Inc stockMarket Sentiment Shifts & Low Risk Trading Alerts - earlytimes.in
Mangoceuticals (NASDAQ:MGRX) Stock Price Down 4% – Should You Sell? - Defense World
Is Mangoceuticals Inc. forming a bottoming baseJuly 2025 Big Picture & Weekly Top Gainers Alerts - newser.com
How to interpret RSI for Mangoceuticals Inc. stock2025 Retail Activity & Safe Investment Capital Preservation Plans - newser.com
Forecast Cut: Can Mangoceuticals Inc expand into new marketsJuly 2025 Analyst Calls & Low Drawdown Trading Techniques - خودرو بانک
Smart tools for monitoring Mangoceuticals Inc.’s price actionTrade Exit Summary & Stepwise Trade Signal Implementation - newser.com
Recap Report: Can Mangoceuticals Inc ride the EV wave2025 Market Outlook & Free Safe Capital Growth Stock Tips - خودرو بانک
How high can Mangoceuticals Inc. stock goTrade Risk Summary & Free Growth Oriented Trading Recommendations - newser.com
Can trapped investors hope for a rebound in Mangoceuticals Inc.New Guidance & Capital Efficiency Focused Strategies - newser.com
Custom watchlist performance reports with Mangoceuticals Inc.GDP Growth & Weekly Market Pulse Alerts - newser.com
Sentiment Review: What are the future prospects of Mangoceuticals Inc2025 Retail Activity & Risk Managed Investment Entry Signals - خودرو بانک
Targets Report: Can Mangoceuticals Inc expand into new marketsMarket Risk Summary & Low Risk Profit Maximizing Plans - خودرو بانک
Macro Review: Whats the profit margin of Mangoceuticals Inc2025 Biggest Moves & Weekly Return Optimization Plans - khodrobank.com
Automated trading signals detected on Mangoceuticals Inc.Market Sentiment Review & Safe Capital Preservation Plans - newser.com
Forecast Cut: Is Mangoceuticals Inc being accumulated by smart moneyJuly 2025 Reactions & Risk Controlled Stock Pick Alerts - khodrobank.com
Risks Report: Will Mangoceuticals Inc benefit from seasonalityWeekly Trade Analysis & Community Consensus Trade Alerts - khodrobank.com
Visual trend scoring systems applied to Mangoceuticals Inc.Trade Entry Report & Step-by-Step Swing Trade Plans - newser.com
Price momentum metrics for Mangoceuticals Inc. explainedWeekly Risk Report & Consistent Profit Alerts - newser.com
Is Mangoceuticals Inc. stock ready for a breakoutJobs Report & AI Driven Stock Reports - newser.com
Detecting support and resistance levels for Mangoceuticals Inc.2025 Stock Rankings & Long-Term Investment Growth Plans - newser.com
Does Mangoceuticals Inc. show high probability of reboundMarket Growth Summary & Risk Managed Trade Strategies - newser.com
Dividend Watch: What is Mangoceuticals Incs revenue forecastMarket Sentiment Review & Low Risk High Win Rate Picks - خودرو بانک
Bear Alert: Should I average down on VTAK stockWeekly Stock Summary & Reliable Breakout Forecasts - khodrobank.com
Price Action: Will Amarin Corporation plc Depositary Receipt benefit from government policyMarket Volume Report & Capital Protection Trade Alerts - خودرو بانک
Aug Swings: Is Mangoceuticals Inc. forming a breakout patternTrade Volume Report & Weekly Breakout Stock Alerts - خودرو بانک
Long term hold vs stop loss in Mangoceuticals Inc.2025 Performance Recap & AI Forecast Swing Trade Picks - newser.com
Mangoceuticals Inc Stock (MGRX) Financials Data
Revenue
Net Income
Cash Flow
EPS
8.35%
1.76%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):